Literature DB >> 29686707

Corrigendum to "Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema".

Eva Rye Rasmussen1, Christian von Buchwald1, Mia Wadelius2, Sumangali Chandra Prasad3, Shailajah Kamaleswaran3, Kawa Khaled Ajgeiy3, Georg Authried3, Kristine Appel U Pallesen3, Anette Bygum3.   

Abstract

[This corrects the article DOI: 10.1155/2017/1476402.].

Entities:  

Year:  2018        PMID： 29686707      PMCID： PMC5852895          DOI： 10.1155/2018/9169414

Source DB:  PubMed          Journal:  Int J Otolaryngol        ISSN： 1687-9201


In the article titled “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema” [1], there was an error in the Results section where the text reading “In multivariate logistic regression analysis, angioedema located in the head and neck region was nonsignificantly associated with admission (odds ratio (OR) 5.9 (p = 0.15, 95% CI 0.53–98.49)), while angioedema in peripheral sites was significantly associated with not being admitted (OR 0.15 (p = 0.05 95% CI, 0.01–0.95) (Table 6))” should be corrected as follows. “In multivariate logistic regression analysis, angioedema located in the head and neck region was nonsignificantly associated with admission (odds ratio (OR) 6.93 (p = 0.14, 95% CI 0.53–98.49)), while angioedema in peripheral sites was significantly associated with not being admitted (OR 0.15 (p = 0.05 95% CI, 0.01–0.95) (Table 6)).”
  1 in total

1.  Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema.

Authors:  Eva Rye Rasmussen; Christian von Buchwald; Mia Wadelius; Sumangali Chandra Prasad; Shailajah Kamaleswaran; Kawa Khaled Ajgeiy; Georg Authried; Kristine Appel U Pallesen; Anette Bygum
Journal:  Int J Otolaryngol       Date:  2017-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.